13566 Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Notices 

OMB Review; Comment Request.’’ That 

notice invited public comments on the 

following information collection 

request: Title: Generic Clearance for 

Medicaid and CHIP State Plan, Waiver, 

and Program Submissions; Form 

Number: CMS–10398; and OMB Control 

Number: 0938–1148. Through the 

publication of this document we are 

withdrawing that notice (FR document: 

2021–04052) in its entirety. Before the 

end of March 2021, we intend to 

publish a notice that sets out our revised 

process for making CMS–10398-specific 

generic information collections (also 

known as ‘‘GenICs’’) available for public 

review and comment. 

Dated: March 4, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–04885 Filed 3–8–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10225 and CMS– 

10769] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

May 10, 2021. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10225 Disclosures Required of 

Certain Hospitals and Critical 

Access Hospitals Regarding 

Physician Ownership 

CMS–10769 Evaluation of the Centers 

for Medicare & Medicaid Services 

(CMS) Network of Quality 

Improvement and Innovation 

Contractors (NQIIC) 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Reinstatement of a previously 

approved collection; Title of 

Information Collection: Disclosures 

Required of Certain Hospitals and 

Critical Access Hospitals Regarding 

Physician Ownership; Use: This 

information collection relates to the 

required third party disclosures by 

certain Medicare-participating hospitals 

and Critical Access Hospitals (CAHs) 

and physicians to their patients. There 

are 5 types of disclosures required. The 

intent of the disclosure notice is to 

assist the patient in making an informed 

decision regarding their care. The first 

disclosure requires physician owned 

hospitals and CAHs to disclose to its 

patients whether the hospitals/CAHs are 

physician-owned and, if so, the names 

of the physician-owners. The second 

disclosure requires the physician owner 

or investor in the hospital, as part of his 

or her continued medical staff 

membership or admitting privileges, to 

disclose to the patient being referred to 

the hospital any ownership or 

investment interest held by the 

physician or an immediate family 

member of the physician. The third 

disclosure requires physician owned 

hospitals to disclose on all public 

websites for and in any public 

advertising for the hospital that the 

hospital is owned or invested in by 

physicians. The fourth and fifth 

disclosures apply to all hospitals and 

CAHs that do not have a Doctor of 

Medicine (MD) or a Doctor of 

Osteopathic Medicine (DO) on the 

premises at all times to disclose this to 

patients upon admission or registration 

for both inpatient and specified 

outpatient services. These hospitals and 

CAHs must provide a written disclosure 

to the patients admitted to the hospital 

and must also post a conspicuous notice 

in the Emergency Departments (ED) 

which states that the hospital does not 

a physician present 24 hours per day, 7 

days per week. Form Number: CMS– 

10225 (OMB control number: 0938– 

1034); Frequency: Occasionally; 

Affected Public: Private sector— 

Business or other for-profits and Notfor-profit institutions; Number of 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 44 / Tuesday, March 9, 2021 / Notices 13567 

Respondents: 322; Total Annual 

Responses: 4,675,575; Total Annual 

Hours: 78,935. (For policy questions 

regarding this collection contact 

Caroline Gallaher at 410–786–8705). 

2. Type of Information Collection 

Request: New collection (Request for a 

new OMB control number); Title of 

Information Collection: Evaluation of 

the Centers for Medicare & Medicaid 

Services (CMS) Network of Quality 

Improvement and Innovation 

Contractors (NQIIC); Use: The purpose 

of this Information Collection Request 

(ICR) is to collect data using telephone 

surveys to inform the program 

evaluation of the CMS NQIIC initiative. 

The purpose of NQIIC is to support 

quality improvement efforts across 

settings and programs for maximum 

impact to health care and value to 

taxpayers in a manner that aligns with 

CMS’ and Department of Health and 

Human Services (HHS) priorities. The 

NQIIC quality improvement efforts 

involve the QIN–QIO Program, which is 

one of the largest federal programs 

dedicated to improving health quality 

for Medicare beneficiaries. 

CMS evaluates the quality and 

effectiveness of the QIN–QIO Program 

as authorized in Part B of Title XI of the 

Social Security Act. This ICR is to 

conduct data collection using surveys 

with administrators or managers of 

nursing homes and hospitals. Form 

Number: CMS–10769 (OMB control 

number: 0938–NEW); Frequency: 

Yearly; Affected Public: Private Sector: 

Business or other for-profits; Number of 

Respondents: 1,010; Total Annual 

Responses: 1,010; Total Annual Hours: 

300. (For policy questions regarding this 

collection, contact Nancy Sonnenfeld at 

410–786–1294.) 

Dated: March 3, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–04798 Filed 3–8–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of NHLBI P01 Applications. 

Date: June 2, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 45 

Center Drive, Bethesda, MD 20892 (Video 

Meeting). 

Contact Person: Brian R. Pike, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN18, Bethesda, MD 

20892, (301) 594–3907, pikebr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: March 3, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–04815 Filed 3–8–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurobiology of Glia. 

Date: March 25, 2021. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Peter B. Guthrie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1239, guthriep@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Infectious, Foodborne, and 

Waterborne Disease Diagnostics and Methods 

in Microbial Sterilization and Disinfection. 

Date: April 1–2, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Gagan Pandya, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, RM 3200, MSC 7808, 

Bethesda, MD 20892, (301) 435–1167, 

pandyaga@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurodifferentiation, Plasticity, Regeneration 

and Rhythmicity (R21). 

Date: April 5, 2021. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joanne T. Fujii, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4184, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1178, fujiij@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Endocrinology, Metabolism, 

Nutrition and Reproductive Sciences. 

Date: April 6, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Gregory S. Shelness, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6156, 

Bethesda, MD 20892–7892, (301) 755–4335, 

greg.shelness@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Innovative Research in Cancer 

Nanotechnology. 

Date: April 6–7, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


khammond on DSKJM1Z7X2PROD with NOTICES